Vycor Medical Inc
VYCO· OTC
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001145443-12-000957
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $265.39K | $142.33K | $74.82K |
| Net Income | -$797.73K | -$1.84M | -$420.19K |
| EPS Diluted | -$0.14 | -$0.00 | -$0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end